Pilot of a New Cognitive Assessment Tool for Detecting Dementia in the Migrant Somali Population

December 15, 2023 updated by: Sophie Jeffery, Greater Manchester Mental Health NHS Foundation Trust

Aims

  • The investigators want to find out if the tool that they have made to assess memory and thinking in Somali elders ( the 'MSCAT') is acceptable to that community and practical to administer and score.
  • The public will benefit from this research because it seeks to enhance reliability of diagnosis of dementia, thus access to support and treatment for people from an ethnic minority group experiencing memory problems.

Background

  • The investigators are a group of staff from the Memory Assessment Service in Manchester. There are currently no suitable tests for dementia for people from Somalia.
  • Research evidence tells us there are many reasons why the tools that used now are not working. This includes: differences in culture and ways of life that are very different to a British born person who has lived in the UK for all of their life.
  • Somali people find out at a later stage if they have dementia resulting in delayed treatment/support.
  • This research supports the government's promise to improve the pathway to a diagnosis of dementia for minority groups.

Design and methods

  • 10 participants
  • The investigators will compare the assessment tool (MSCAT) that the team have developed to the Addenbrookes Cognitive Examination III tool that is typically used.
  • Participants will be seen at an agreed location (e.g. home, mosque or GMMH trust site). They will meet a Somali speaking researcher to do both tests on 2 appointments and discuss how they found the tests afterwards.
  • The investigators will check participants understanding of the research before they agree to take part. Verbal and written information will be provided.

Public involvement

  • The local Somali community helped advise on the creation of the new MSCAT assessment tool.
  • The investigators will write project information for participants in Somali and English.

Dissemination of results

• Professional conference presentations and publications

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United Kingdom
      • Manchester, United Kingdom, M13 9WL
        • Greater Manchester Mental Health NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Somali-born migrants in UK

Description

Inclusion Criteria:

  • The participants will all be Somali-born migrants, over the age of 50, living in the UK.

Exclusion Criteria:

  • Exclusion criteria will include the presence of dementia, current delirium, or inability to complete the tasks due to visual/hearing/physical impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Participants
Somali migrants in UK, aged over 50.
Diagnostic test: Manchester Somali Cognitive Assessment Tool
Cognitive screen for dementia
Diagnostic test: ACE-III Somali Translation
Cognitive screen for dementia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualitative feedback on completing the cognitive screens
Time Frame: Immediately after completing the screen
Interview
Immediately after completing the screen

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Greater Manchester Mental Health NHS Foundation Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2022

Primary Completion (Actual)

December 4, 2023

Study Completion (Actual)

December 4, 2023

Study Registration Dates

First Submitted

December 7, 2021

First Submitted That Met QC Criteria

December 7, 2021

First Posted (Actual)

December 20, 2021

Study Record Updates

Last Update Posted (Estimated)

December 18, 2023

Last Update Submitted That Met QC Criteria

December 15, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • x503s

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Manchester Somali Cognitive Assessment Tool

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe